Lyser 20mg Tablet contains Serratiopeptidase 20mg, a proteolytic enzyme widely used for its anti-inflammatory, analgesic, and fibrinolytic properties. This medication is primarily indicated for the management of inflammatory conditions, including postoperative swelling, trauma, and chronic inflammatory diseases such as arthritis and sinusitis. Serratiopeptidase acts by breaking down abnormal or excess proteins at the site of inflammation, thereby reducing edema and facilitating the resolution of inflammatory exudates. It also promotes the degradation of fibrin and other dead tissue components, enhancing tissue repair and improving blood flow in affected areas. Lyser 20mg is commonly prescribed to alleviate pain and inflammation associated with musculoskeletal disorders, respiratory tract infections, and soft tissue injuries. The drug is generally well tolerated, with a low incidence of adverse effects; however, caution is advised in patients with bleeding disorders or those on anticoagulant therapy due to its fibrinolytic activity. It is recommended to administer Lyser 20mg under medical supervision, adhering to prescribed dosages to optimize therapeutic outcomes. Patients should inform their healthcare provider of any allergies or concurrent medications prior to initiating treatment with Lyser 20mg Tablet.